FASEB J. Mp Biomedicals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
fj.07-8116comv1
21/11/2980    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Urayama, K.
Right arrow Articles by Nebigil, C. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Urayama, K.
Right arrow Articles by Nebigil, C. G.
Published online before print April 18, 2007 as doi: 10.1096/fj.07-8116com.

The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis

Kyoji Urayama, Célia Guilini, Nadia Messaddeq, Kai Hu, Marja Steenman, Hitoshi Kurose, Georg Ert, and Canan G. Nebigil

E-mail contact: nebigil@esbs.u-strasbg.fr

Prokineticins are potent angiogenic factors that bind to two G protein-coupled receptors to initiate their biological effects. We hypothesize that prokineticin receptor-1 (PKR1/GPR73) signaling may contribute to cardiomyocyte survival or repair in myocardial infarction. Since we showed that prokineticin-2 and PKR1 are expressed in adult mouse heart and cardiac cells, we investigated the role of prokineticin-2 on capillary endothelial cell and cardiomyocyte function. In cultured cardiac endothelial cells, prokineticin-2 or overexpression of PKR1 induces vessel-like formation without increasing VEGF levels. In cardiomyocytes and H9c2 cells, prokineticin-2 or overexpressing PKR1 activates Akt to protect cardiomyocytes against oxidative stress. The survival and angiogenesis promoting effects of prokineticin-2 in cardiac cells were completely reversed by siRNA-PKR1, indicating PKR1 involvement. We thus, further investigated whether intramyocardial gene transfer of DNA encoding PKR1 may rescue the myocardium against myocardial infarction in mouse model. Transient PKR1 gene transfer after coronary ligation reduces mortality and preserves left ventricular function by promoting neovascularization and protecting cardiomyocytes without altering VEGF levels. In human end-stage failing heart samples, reduced PKR1 and prokineticin-2 transcripts and protein levels implicate a more important role for prokineticin-2/PKR1 signaling in heart. Our results suggest that PKR1 may represent a novel therapeutic target to limit myocardial injury following ischemic events.--Urayama, K., Guilini, C., Messaddeq, N., Hu, K., Steenman, M., Kurose, H., Ert, G., Nebigil, C. G. The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis




This article has been cited by other articles:


Home page
 Circ. Res.Home page
H. E. Olivey and E. C. Svensson
Epicardial-Myocardial Signaling Directing Coronary Vasculogenesis
Circ. Res., March 19, 2010; 106(5): 818 - 832.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
C. T. Cottage, B. Bailey, K. M. Fischer, D. Avitable, B. Collins, S. Tuck, P. Quijada, N. Gude, R. Alvarez, J. Muraski, et al.
Cardiac Progenitor Cell Cycling Stimulated by Pim-1 Kinase
Circ. Res., March 19, 2010; 106(5): 891 - 901.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
I. H. Cook, J. Evans, D. Maldonado-Perez, H. O. Critchley, K. J. Sales, and H. N. Jabbour
Prokineticin-1 (PROK1) modulates interleukin (IL)-11 expression via prokineticin receptor 1 (PROKR1) and the calcineurin/NFAT signalling pathway
Mol. Hum. Reprod., March 1, 2010; 16(3): 158 - 169.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
C. Guilini, K. Urayama, G. Turkeri, D. B. Dedeoglu, H. Kurose, N. Messaddeq, and C. G. Nebigil
Divergent roles of prokineticin receptors in the endothelial cells: angiogenesis and fenestration
Am J Physiol Heart Circ Physiol, March 1, 2010; 298(3): H844 - H852.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
H. Attramadal
Prokineticins and the heart: diverging actions elicited by signalling through prokineticin receptor-1 or -2
Cardiovasc Res, January 1, 2009; 81(1): 3 - 4.
[Full Text] [PDF]

Home page
 Cardiovasc ResHome page
K. Urayama, D. B. Dedeoglu, C. Guilini, S. Frantz, G. Ertl, N. Messaddeq, and C. G. Nebigil
Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage
Cardiovasc Res, January 1, 2009; 81(1): 28 - 37.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. C. Denison, S. Battersby, A. E. King, M. Szuber, and H. N. Jabbour
Prokineticin-1: A Novel Mediator of the Inflammatory Response in Third-Trimester Human Placenta
Endocrinology, July 1, 2008; 149(7): 3470 - 3477.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
K. Urayama, C. Guilini, G. Turkeri, S. Takir, H. Kurose, N. Messaddeq, A. Dierich, and C. G. Nebigil
Prokineticin Receptor-1 Induces Neovascularization and Epicardial-Derived Progenitor Cell Differentiation
Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 841 - 849.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by The Federation of American Societies for Experimental Biology.